A 59-year-old man presented with a two-week history of epigastric pain associated with itching and jaundice. Laboratory investigation: direct bilirubin 15xN; alkaline phosphatase 3xN; gamma-GT 6xN; glucose 2.5xN, and normal levels of both amylase and lipase. CT scan of the abdomen showed diffuse large pancreas with delay in the uptake of contrast product, as well as loss of normal pancreatic lobulation and a heterogeneous nodular area in the cephalic portion. Abdominal MRI revealed sausage like swelling of the pancreas with a surrounding low attenuation rim and a heterogeneous 
A 59-year-old man presented with a two-week history of epigastric pain associated with itching and jaundice. Laboratory investigation: direct bilirubin 15xN; alkaline phosphatase 3xN; gamma-GT 6xN; glucose 2.5xN, and normal levels of both amylase and lipase. CT scan of the abdomen showed diffuse large pancreas with delay in the uptake of contrast product, as well as loss of normal pancreatic lobulation and a heterogeneous nodular area in the cephalic portion. Abdominal MRI revealed sausage like swelling of the pancreas with a surrounding low attenuation rim and a heterogeneous nodular area in the cephalic portion (Fig. 1) . Endoscopic ultrasound confirmed the heterogeneity of the pancreatic cephalic portion with a 40 mm nodule (Fig. 2) . Aspiration cytology guided by endoscopic ultrasound was performed, and showed marked parenchymal lymphoplasmacytic infiltration, storiform fibrosis and obliterative phlebitis without malignant cells ( Fig. 3A and B) . Serologically, quantification of IgG subclasses allowed the discrimination of a raised IgG4 7xN. The diagnosis of autoimmune pancreatitis (AIP) was thus established, and the patient was proposed for corticosteroid therapy that, however, he has refused. A normalization of cholestatic enzymes was observed while the patient was still at the hospital and, after 8 months from diagnosis, the patient remains asymptomatic without any laboratory abnormality or evidence of involvement of other organs by the sclerosing process namely salivary glands, biliary tract, lungs, thyroid or kidneys.
AIP is the pancreatic manifestation of a rare, systemic disease. 1 Its diagnosis relies on a combination of clinical, serological, histological and imaging criteria. 2 It is imperative to differentiate AIP from pancreatic cancer owing to the vastly different prognostic and therapeutic implications. 1, 2 In the case presented above features such as sex, age, symptoms, diabetes and typical imaging raised the suspicion of AIP that was then confirmed by the presence of an increased IgG4 and the exclusion of pancreatic cancer. Although the patient refused therapy with corticosteroids there was a complete clinical and laboratorial remission, which did not surprise us since, while therapy with corticosteroids is recommended especially for patients with obstructive jaundice, 3 there have been reports of spontaneous resolution of pancreatic masses, strictures, and jaundice in the context of AIP. 4 
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